4-Oxo-Fenretinide, a Recently Identified Fenretinide Metabolite, Induces Marked G2-M Cell Cycle Arrest and Apoptosis in Fenretinide-Sensitive and Fenretinide-Resistant Cell Lines

Cancer Research - United States
doi 10.1158/0008-5472.can-05-3362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells Through Induction of Cytochrome P450 26A1

Clinical Cancer Research
Cancer ResearchOncology
2004English

Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia

Clinical Cancer Research
Cancer ResearchOncology
2006English

P75NTR: An Enhancer of Fenretinide Toxicity in Neuroblastoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Ovarian and Breast Cancer Spheres Are Similar in Transcriptomic Features and Sensitive to Fenretinide

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Phase II Trial of Fenretinide in Advanced Renal Carcinoma

Investigational New Drugs
OncologyPharmacology
2005English

Zerumbone Induces G2/M Cell Cycle Arrest and Apoptosis via Mitochondrial Pathway in Jurkat Cell Line

Natural Product Communications
PharmacologyComplementaryPlant ScienceAlternative MedicineMedicineDrug Discovery
2014English

Development of PLGA-Based Injectable Delivery Systems for Hydrophobic Fenretinide

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2010English

Fenretinide Promotes Functional Recovery and Tissue Protection After Spinal Cord Contusion Injury in Mice

Journal of Neuroscience
Neuroscience
2010English

A New Bioavailable Fenretinide Formulation With Antiproliferative, Antimetabolic, and Cytotoxic Effects on Solid Tumors

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy